Select Medical (SEM) shares plummeted 9.59% in pre-market trading on Friday following the release of its first-quarter earnings report, which fell short of analyst expectations and included a reduction in annual revenue guidance.
The healthcare company reported earnings from continuing operations of $0.44 per diluted share for Q1, up from $0.33 a year earlier but below the $0.46 anticipated by analysts polled by FactSet. Revenue for the quarter ended March 31 came in at $1.35 billion, missing the $1.39 billion forecast and only slightly higher than the $1.32 billion reported in the same period last year.
Adding to investor concerns, Select Medical trimmed its 2025 revenue guidance to a range of $5.3 billion to $5.5 billion, down from its previous forecast of $5.4 billion to $5.6 billion. This adjustment puts the company's outlook below the $5.46 billion expected by analysts. Despite the revenue guidance cut, Select Medical reaffirmed its 2025 earnings forecast of $1.09 to $1.19 per diluted share, in line with analyst expectations of $1.12.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.